Annual SGA
$484.98 M
+$18.13 M+3.88%
December 31, 2024
Summary
- As of March 13, 2025, GDRX annual SGA is $484.98 million, with the most recent change of +$18.13 million (+3.88%) on December 31, 2024.
- During the last 3 years, GDRX annual SGA has fallen by -$39.93 million (-7.61%).
- GDRX annual SGA is now -32.32% below its all-time high of $716.59 million, reached on December 31, 2020.
Performance
GDRX SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$117.38 M
+$1.89 M+1.64%
December 31, 2024
Summary
- As of March 13, 2025, GDRX quarterly SGA is $117.38 million, with the most recent change of +$1.89 million (+1.64%) on December 31, 2024.
- Over the past year, GDRX quarterly SGA has increased by +$1.89 million (+1.64%).
- GDRX quarterly SGA is now -71.76% below its all-time high of $415.69 million, reached on December 31, 2020.
Performance
GDRX Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$5.80 B
+$16.39 M+0.28%
December 31, 2024
Summary
- As of March 13, 2025, GDRX TTM SGA is -$5.80 billion, with the most recent change of +$16.39 million (+0.28%) on December 31, 2024.
- Over the past year, GDRX TTM SGA has dropped by -$6.29 billion (-1279.30%).
- GDRX TTM SGA is now -428.70% below its all-time high of -$1.10 billion.
Performance
GDRX TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
GDRX Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +3.9% | +1.6% | -1279.3% |
| 3 y3 years | -7.6% | -7.5% | -1373.3% |
| 5 y5 years | +153.0% | -7.5% | -1373.3% |
GDRX Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -7.6% | +3.9% | -17.3% | +9.0% | -4.7% | +0.3% |
| 5 y | 5-year | -32.3% | +153.0% | -71.8% | +101.5% | -428.7% | +0.3% |
| alltime | all time | -32.3% | +330.9% | -71.8% | +139.3% | -428.7% | +0.3% |
GoodRx Holdings Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $484.98 M(+3.9%) | $117.38 M(+1.6%) | $484.98 M(-1.4%) |
| Sep 2024 | - | $115.49 M(-4.6%) | $491.72 M(-2.3%) |
| Jun 2024 | - | $121.04 M(-7.7%) | $503.17 M(+2.7%) |
| Mar 2024 | - | $131.07 M(+5.6%) | $489.77 M(+4.9%) |
| Dec 2023 | $466.84 M(-7.1%) | $124.12 M(-2.2%) | $466.84 M(+2.5%) |
| Sep 2023 | - | $126.93 M(+17.9%) | $455.43 M(-1.9%) |
| Jun 2023 | - | $107.65 M(-0.5%) | $464.26 M(-4.4%) |
| Mar 2023 | - | $108.14 M(-4.1%) | $485.69 M(-3.3%) |
| Dec 2022 | $502.42 M | $112.71 M(-17.0%) | $502.42 M(-5.5%) |
| Sep 2022 | - | $135.76 M(+5.2%) | $531.58 M(+0.8%) |
| Jun 2022 | - | $129.08 M(+3.4%) | $527.41 M(+0.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $124.87 M(-12.0%) | $526.30 M(+0.3%) |
| Dec 2021 | $524.90 M(-26.7%) | $141.87 M(+7.8%) | $524.90 M(-34.3%) |
| Sep 2021 | - | $131.60 M(+2.8%) | $798.73 M(-5.0%) |
| Jun 2021 | - | $127.96 M(+3.6%) | $840.73 M(+9.0%) |
| Mar 2021 | - | $123.48 M(-70.3%) | $771.02 M(+7.6%) |
| Dec 2020 | $716.59 M(+273.9%) | $415.69 M(+139.5%) | $716.59 M(+99.2%) |
| Sep 2020 | - | $173.59 M(+198.0%) | $359.75 M(+52.9%) |
| Jun 2020 | - | $58.25 M(-15.6%) | $235.21 M(+32.9%) |
| Mar 2020 | - | $69.05 M(+17.3%) | $176.96 M(+64.0%) |
| Dec 2019 | $191.66 M(+70.3%) | $58.85 M(+20.0%) | $107.91 M(+120.0%) |
| Sep 2019 | - | $49.05 M | $49.05 M |
| Dec 2018 | $112.54 M | - | - |
FAQ
- What is GoodRx Holdings annual SGA?
- What is the all time high annual SGA for GoodRx Holdings?
- What is GoodRx Holdings annual SGA year-on-year change?
- What is GoodRx Holdings quarterly SGA?
- What is the all time high quarterly SGA for GoodRx Holdings?
- What is GoodRx Holdings quarterly SGA year-on-year change?
- What is GoodRx Holdings TTM SGA?
- What is the all time high TTM SGA for GoodRx Holdings?
- What is GoodRx Holdings TTM SGA year-on-year change?
What is GoodRx Holdings annual SGA?
The current annual SGA of GDRX is $484.98 M
What is the all time high annual SGA for GoodRx Holdings?
GoodRx Holdings all-time high annual SGA is $716.59 M
What is GoodRx Holdings annual SGA year-on-year change?
Over the past year, GDRX annual SGA has changed by +$18.13 M (+3.88%)
What is GoodRx Holdings quarterly SGA?
The current quarterly SGA of GDRX is $117.38 M
What is the all time high quarterly SGA for GoodRx Holdings?
GoodRx Holdings all-time high quarterly SGA is $415.69 M
What is GoodRx Holdings quarterly SGA year-on-year change?
Over the past year, GDRX quarterly SGA has changed by +$1.89 M (+1.64%)
What is GoodRx Holdings TTM SGA?
The current TTM SGA of GDRX is -$5.80 B
What is the all time high TTM SGA for GoodRx Holdings?
GoodRx Holdings all-time high TTM SGA is -$1.10 B
What is GoodRx Holdings TTM SGA year-on-year change?
Over the past year, GDRX TTM SGA has changed by -$6.29 B (-1279.30%)